Caris Life Sciences alternatives and competitors
The closest alternatives to Caris Life Sciences are BostonGene, Guardant Health, Caristo Diagnostics and Veracyte.
Caris Life Sciences (NASDAQ: CAI) is a precision oncology company in Irving, Texas. It profiles tumors in its own laboratories by whole exome and whole transcriptome sequencing and layers AI signatures on the results.
10 alternatives to Caris Life Sciences
What each product does, with its price as the vendor publishes it.
-
B
Precision oncology company in Waltham, Massachusetts, combining sequencing in its own CAP accredited, CLIA certified laboratory with models of tumor and immune biology.
Price: No published price
-
G
Guardant Health is a publicly traded precision oncology company (Nasdaq: GH), founded in 2012 and based in Palo Alto, California, that runs blood and tissue cancer tests in its own laboratories.
-
C
Caristo Diagnostics, an Oxford spinout, measures coronary inflammation from the same routine coronary CT angiogram used to assess plaque.
Price: No published price
-
V
Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Price: No published price
-
G
Multi cancer early detection company (NASDAQ: GRAL). The Galleri test uses targeted methylation sequencing of cell free DNA from a blood draw, with machine learning classifiers that detect a cancer signal and predict its origin, across more than 50 cancer types.
Price: $949 per test (list price)
-
4
Precision oncology company running hospital linked genomics laboratories in India, the United Arab Emirates, Nepal and the Philippines.
Price: No published price
-
F
Foundation Medicine, based in Boston and a member of the Roche Group, runs comprehensive genomic profiling for cancer in its own laboratories.
Price: No published price
-
G
Rare disease genomic diagnosis company (NASDAQ: WGS) in Gaithersburg, Maryland, running exome and genome sequencing in its own accredited laboratory and interpreting it with automation, machine learning and clinical scientists over GeneDx Infinity, its dataset of prior cases.
Price: No published price
-
F
Cancer screening company (NASDAQ: FRNM) whose blood tests run on a multiomics platform that reads cell free DNA methylation at single base resolution, alongside protein and autoantibody signals, with machine learning classifiers producing the result.
Price: No published price
-
H
Genomics company in San Mateo, California, sequencing with its proprietary Exome+ assay in a CLIA certified, CAP accredited laboratory.
Price: No published price
More Caris Life Sciences comparisons
Side by side comparisons of Caris Life Sciences with products not listed above.
Caris Life Sciences alternatives, answered
What are the best alternatives to Caris Life Sciences?
The closest alternatives to Caris Life Sciences are BostonGene, Guardant Health, Caristo Diagnostics, Veracyte and GRAIL. Guardant Health is a publicly traded precision oncology company (Nasdaq: GH), founded in 2012 and based in Palo Alto, California, that runs blood and tissue cancer tests in its own laboratories. Caristo Diagnostics, an Oxford spinout, measures coronary inflammation from the same routine coronary CT angiogram used to assess plaque. Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Who are Caris Life Sciences's competitors?
Caris Life Sciences's competitors in the Diagnostics & Genomics category include BostonGene, Guardant Health, Veracyte, GRAIL, 4baseCare and Foundation Medicine.